The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Ian T. Meredith

Showing 1-20 of 24 articles
Interventions for valvular disease
Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
Gooley R, Worthley S, Whitbourn R, Montarello J, Newcomb A, Allocco D, Meredith I
December 7, 2018 | 10.4244/EIJ-D-18-00664
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco D
April 20, 2018 | 10.4244/EIJ-D-17-00529
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Coronary interventions
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy
Kereiakes D, Meredith I, Masotti M, Carrié D, Moreno R, Erglis A, Mehta S, Elhadad S, Berland J, Stein B, Airaksinen J, Jobe R, Reitman A, Janssens L, Christen T, Dawkins K, Windecker S
March 20, 2017 | 10.4244/EIJ-D-16-00643
Coronary interventions
Intravascular ultrasound guidance improves clinical outcomes during implantation of both first- and second-generation drug-eluting stents: a meta-analysis
Nerlekar N, Cheshire C, Verma K, Ihdayhid A-R, McCormick L, Cameron J, Bennett M, Malaiapan Y, Meredith I, Brown A
January 20, 2017 | 10.4244/EIJ-D-16-00769
Interventions for valvular disease
Intrepid transcatheter mitral valve replacement system: technical and product description
Meredith I, Bapat V, Morriss J, McLean M, Prendergast B
September 18, 2016 | 10.4244/EIJV12SYA21
Coronary interventions
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program
Abdel-Wahab M, Neumann F, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimsky P, Meredith I, Saito S, Richardt G
July 20, 2016 | 10.4244/EIJY15M07_07
Interventions for valvular disease
The Accucinch transcatheter direct mitral valve annuloplasty system
Gooley R, Meredith I
September 17, 2015 | 10.4244/EIJV11SWA16
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial
Sakata K, Boo B, Waseda K, Nakatani D, Yock P, Whitbourn R, Worthley S, Ormiston J, Webster M, Wilkins G, Honda Y, Meredith I, Fitzgerald P
March 20, 2015 | 10.4244/EIJY14M08_16
Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study
Sievert H, Schofer J, Ormiston J, Hoppe U, Meredith I, Walters D, Azizi M, Diaz-Cartelle J, Cohen-Mazor M
February 20, 2015 | 10.4244/EIJY14M12_01
Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study
Meredith I, Worthley S, Whitbourn R, Antonis P, Montarello J, Newcomb A, Lockwood S, Haratani N, Allocco D, Dawkins K
March 20, 2014 | 10.4244/EIJV9I11A216
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Serruys P, Onuma Y, Garcia-Garcia H, Muramatsu T, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert K, Rapoza R, Ormiston J
March 20, 2014 | 10.4244/EIJV9I11A217
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study
Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky A, Bichalska M, Meis S, Verheye S
September 27, 2013 | 10.4244/EIJV9I5A93
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco D, Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
How should I treat a patient with symptomatic severe aortic stenosis and a 23 mm aortic annulus who is referred for transcatheter aortic valve replacement using the CoreValve prosthesis?
Ko B, Antonis P, Meredith I, Tchétché D, Eggebrecht H, Zierer A, Doss M
February 22, 2013 | 10.4244/EIJV8I10A186
Boston Scientific Lotus valve
Meredith I, Hood K, Haratani N, Allocco D, Dawkins K
September 30, 2012 | 10.4244/EIJV8SQA12
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials
Kereiakes D, Popma J, Cannon L, Kandzari D, Kimmelstiel C, Meredith I, Teirstein P, Verheye S, Allocco D, Dawkins K, Stone G
June 27, 2012 | 10.4244/EIJV8I2A32
First-in-human experience with the Medtronic Bifurcation Stent System
Meredith I, Worthley S, Whitbourn R, Webster M, Fitzgerald P, Ormiston J
October 28, 2011 | 10.4244/EIJV7I6A108
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses
Meredith I, Whitbourn R, Scott D, El-Jack S, Zambahari R, Stone G, Teirstein P, Starzyk R, Allocco D, Dawkins K
May 17, 2011 | 10.4244/EIJV7I1A15

Latest news

NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
NEW
Ahead of print: Leaflex Study
September 23, 2020
Editorial
Integrating physiology in OCT
Gianluca Campo
September 23, 2020
PCR Trials
BioFlow IV, TWILIGHT, Evolut Low Risk and many others
(Released thanks to the support of Biotronik)
September 25, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Steady-state hyperaemia
G.G. Toth
September 18, 2020
JAA
This Week's JAA's: Biograde Study, Advances in valvular heart interventions...
September 22, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke